Skip to Main Content

About Omecu

Omecu Ltd promises wide-ranging benefits in drug discovery and personalised medicine, while improving patient data security. A spin out from the University of Edinburgh, the company was formed in early 2021 to commercialise the research and development work from the university in this area.


About the team

Omecu Ltd is co-founded and draws on three years of research by Dr Canela-Xandri and Dr Rawlik alongside CEO Les Gaw, an experienced entrepreneur, investor and adviser to early-stage technology companies, who was introduced to the research team by Edinburgh Innovations.

  • Dr Oriol Canela-Xandri

    Dr Oriol Canela-Xandri

    Chief Technology Officer

    Oriol is based at the MRC Genetics Unit at the University of Edinburgh.

    Oriol has been working on leading edge problems in the field of genetic data analysis for over 8 years, and the last 3 years developing the Golem prototype.

  • Dr Konrad Rawlik

    Dr Konrad Rawlik

    Chief Research Officer

    Konrad is based at the Roslin Institute at the University of Edinburgh. He has extensive experience in the analysis of genetic data and is a specialist in machine learning. He has been working with Oriol for the last 8 years.

  • Les Gaw

    Les Gaw


    Les is an experienced entrepreneur with a computer science background and strong commercial skills.

    He led the exit of  a technology company to a listed business before becoming an investor, advisor and non-exec director to early-stage technology companies.

Trusted by

Our research partners are highly-accredited and established intitutions.

The University of Edinburgh

Dr Canela-Xandri and Rawlik have been supported by Edinburgh Innovations since 2019. Omecu received funding from the University’s Data-Driven Entrepreneurship Seed Fund and Fast Track Mentor initiatives, supported by the Scottish Funding Council.

Medical Research Council Logo
Medical Research Council

MRC funds research at the forefront of science to prevent illness, develop therapies and improve human health. Omecu received funding support from Medical Research Council grants.

Innovate UK Logo
Innovate UK

Omecu was awarded £288,000 from Innovate UK, enabling us to refine the prototype and progress commercial engagement.

Are you a Data Holder?

Request a demo to see how Omecu protects your data.

Learn more

Are you a Researcher?

Sign-up for an exclusive video demo link

Learn more

Get in touch.

Contact our expert team to answer any queries about Omecu.